Market Cap 40.69M
Revenue (ttm) 178.03M
Net Income (ttm) -70.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39.77%
Debt to Equity Ratio -0.36
Volume 62,732,402
Avg Vol 99,358,297
Day's Range N/A - N/A
Shares Out 265.05M
Stochastic %K 55%
Beta 2.49
Analysts Hold
Price Target $0.74

Company Profile

Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA ((famitresgene autoleucel or afami-cel), a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment synovial sarcoma and myxoid liposarcoma; and ADP-5701, which is in Phase 1 clinical trial for the t...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 12 3543 0000
Address:
60 Jubilee Avenue, Milton Park, Abingdon, United Kingdom
HellasManN10
HellasManN10 Oct. 4 at 8:41 PM
$ADAP It seems to me that a final offer between $350 million and $450 million is objectively more realistic, i.e. a share price between 1.3 and 1.7...above 2 is very unlikely...I thank US_Bull for his valuable and generous contributions, I always follow him with pleasure.
1 · Reply
walfofwallstreet
walfofwallstreet Oct. 4 at 7:40 PM
$BURU $BTTC $CHR $GPUS $ADAP 🚨🫶 Keep an eye on this list It will explode Monday💥👀👀👀🐺 I was so happy to hear that I helped someone made half a million🫶🤑🫶 I told you I am trying to help 🫶🤑🫶 All my followers are making bank 🏦 You all gonna be rich 🤑👇👇👇🤑
2 · Reply
US_Bull
US_Bull Oct. 4 at 6:52 PM
$ADAP If theyhit market cap of a billion thats around 3.3$ them im retiring 😂
1 · Reply
duepillagence
duepillagence Oct. 4 at 5:18 PM
$ADAP Yes Tecelra and others under their AUTOLOGOUS arm sold for $500+mil counting upfront payments, royalties and milestones but it's their remaining assets (under their ALLOGENEIC programs) that's the most promising due to their "off the shelf" capabilities. Since these have produced "10 fold the results" in Preclinicals, I suspect the buyer will pursue the rights to these so add another $450-$650+ mil and we've got close to $1 bill transaction by Nov? 😳👀 Since
1 · Reply
US_Bull
US_Bull Oct. 4 at 4:36 PM
$ADAP Taking only the first bullet point is twice our market cap so already there it brings us to .3$ that is not even taking into account the remaining bullet points of regulatory milestone and milestone sales kicking in from uza-cel lets-cel and Tecelra and remaining pipeline given 0 value Prame and CD-70 which have both shown strong anti tumor activity in preclinical models
0 · Reply
US_Bull
US_Bull Oct. 4 at 3:20 PM
$ADAP Their Philly address at the navy space is unchanged as of now not like their main UK and manufacturing spaces put up for sublease. Is anyone in Philly can you go and pop in to see whats going on 😂
1 · Reply
Damage111
Damage111 Oct. 4 at 3:16 PM
$ADAP Show me the money 💵💵💵💵
0 · Reply
walfofwallstreet
walfofwallstreet Oct. 4 at 3:16 PM
Monday fire 🔥list 2🔥👀👀🐺 $ADAP $WORX $CRML $FEMY $RVYL MONDAY let’s go 💰💵💰 All my followers are making bank 🏦 You all gonna be rich 🤑
4 · Reply
US_Bull
US_Bull Oct. 4 at 11:41 AM
$ADAP So not only have they put their headquarter sublease rental but also appears to include their manufacturing facility. Look at the bio names in the second link they are no longer listed on any of the floors. Tick tock tick tock.... https://search.savills.com/property-detail/gb0395l304122 https://www.loopnet.com/Listing/Gunnels-Wood-Rd-Stevenage/36945264/
1 · Reply
US_Bull
US_Bull Oct. 4 at 11:24 AM
$ADAP Like the fact that they ended Friday AH keeping her in the red a big bear trap so that more shorts can jump in. Continuation next week FOMO for Galapagos' November 5th, 2025 decision divestiture of their cell therapy arm to the consortium and that will catapult us up. I see +.2$ end of next week.
1 · Reply
Latest News on ADAP
Adaptimmune Provides Q4 and Full Year 2024 Business Update

Mar 20, 2025, 7:00 AM EDT - 7 months ago

Adaptimmune Provides Q4 and Full Year 2024 Business Update


Adaptimmune Reports Q3 2024 Financial and Business Updates

Nov 13, 2024, 4:05 PM EST - 11 months ago

Adaptimmune Reports Q3 2024 Financial and Business Updates


Adaptimmune's Lete-cel Achieves Primary Endpoint in Pivotal Trial

Nov 13, 2024, 9:00 AM EST - 11 months ago

Adaptimmune's Lete-cel Achieves Primary Endpoint in Pivotal Trial


Adaptimmune Reports Q2 2024 Financial and Business Updates

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Adaptimmune Reports Q2 2024 Financial and Business Updates


Adaptimmune Reports Q1 2024 Financial and Business Updates

May 15, 2024, 7:30 AM EDT - 1 year ago

Adaptimmune Reports Q1 2024 Financial and Business Updates


Adaptimmune: Huge Opportunity Amid Their Setback With Genentech

Apr 26, 2024, 11:00 AM EDT - 1 year ago

Adaptimmune: Huge Opportunity Amid Their Setback With Genentech


Adaptimmune Receives Transfer of IND for Lete-cel Program

Nov 29, 2023, 8:00 AM EST - 2 years ago

Adaptimmune Receives Transfer of IND for Lete-cel Program


HellasManN10
HellasManN10 Oct. 4 at 8:41 PM
$ADAP It seems to me that a final offer between $350 million and $450 million is objectively more realistic, i.e. a share price between 1.3 and 1.7...above 2 is very unlikely...I thank US_Bull for his valuable and generous contributions, I always follow him with pleasure.
1 · Reply
walfofwallstreet
walfofwallstreet Oct. 4 at 7:40 PM
$BURU $BTTC $CHR $GPUS $ADAP 🚨🫶 Keep an eye on this list It will explode Monday💥👀👀👀🐺 I was so happy to hear that I helped someone made half a million🫶🤑🫶 I told you I am trying to help 🫶🤑🫶 All my followers are making bank 🏦 You all gonna be rich 🤑👇👇👇🤑
2 · Reply
US_Bull
US_Bull Oct. 4 at 6:52 PM
$ADAP If theyhit market cap of a billion thats around 3.3$ them im retiring 😂
1 · Reply
duepillagence
duepillagence Oct. 4 at 5:18 PM
$ADAP Yes Tecelra and others under their AUTOLOGOUS arm sold for $500+mil counting upfront payments, royalties and milestones but it's their remaining assets (under their ALLOGENEIC programs) that's the most promising due to their "off the shelf" capabilities. Since these have produced "10 fold the results" in Preclinicals, I suspect the buyer will pursue the rights to these so add another $450-$650+ mil and we've got close to $1 bill transaction by Nov? 😳👀 Since
1 · Reply
US_Bull
US_Bull Oct. 4 at 4:36 PM
$ADAP Taking only the first bullet point is twice our market cap so already there it brings us to .3$ that is not even taking into account the remaining bullet points of regulatory milestone and milestone sales kicking in from uza-cel lets-cel and Tecelra and remaining pipeline given 0 value Prame and CD-70 which have both shown strong anti tumor activity in preclinical models
0 · Reply
US_Bull
US_Bull Oct. 4 at 3:20 PM
$ADAP Their Philly address at the navy space is unchanged as of now not like their main UK and manufacturing spaces put up for sublease. Is anyone in Philly can you go and pop in to see whats going on 😂
1 · Reply
Damage111
Damage111 Oct. 4 at 3:16 PM
$ADAP Show me the money 💵💵💵💵
0 · Reply
walfofwallstreet
walfofwallstreet Oct. 4 at 3:16 PM
Monday fire 🔥list 2🔥👀👀🐺 $ADAP $WORX $CRML $FEMY $RVYL MONDAY let’s go 💰💵💰 All my followers are making bank 🏦 You all gonna be rich 🤑
4 · Reply
US_Bull
US_Bull Oct. 4 at 11:41 AM
$ADAP So not only have they put their headquarter sublease rental but also appears to include their manufacturing facility. Look at the bio names in the second link they are no longer listed on any of the floors. Tick tock tick tock.... https://search.savills.com/property-detail/gb0395l304122 https://www.loopnet.com/Listing/Gunnels-Wood-Rd-Stevenage/36945264/
1 · Reply
US_Bull
US_Bull Oct. 4 at 11:24 AM
$ADAP Like the fact that they ended Friday AH keeping her in the red a big bear trap so that more shorts can jump in. Continuation next week FOMO for Galapagos' November 5th, 2025 decision divestiture of their cell therapy arm to the consortium and that will catapult us up. I see +.2$ end of next week.
1 · Reply
Manjanja
Manjanja Oct. 4 at 1:34 AM
$ADAP can someone explain me why It’s up?
1 · Reply
Mervolo
Mervolo Oct. 4 at 12:14 AM
$BFLY fact that she held her chin up after dat, understandible, profit taking, speaks volumessss. 5 min looks gorgeous. $CJET eh, at least not ,14 🤷‍♀️. If they retest recent lows at ,15 , wouldn t be surprised, but hopefully next week a bounce unless $CHR steals some steam?? Just gotta ride the tide btwn offering and rs we guess or re strategize $ADAP put on a good little show, we think.👏👏👏👏 Those dips in the ,14s looked yummy but kinda fizzled at the end And now, we wait… moohoohhahahaha Wait and try to relax. It a been another crazy week. Coffee or wine??????????
1 · Reply
Play1234
Play1234 Oct. 4 at 12:00 AM
0 · Reply
Altairus
Altairus Oct. 3 at 11:55 PM
0 · Reply
walfofwallstreet
walfofwallstreet Oct. 3 at 11:50 PM
Main over the weekend holds 💰🤑💰 $BTTC 💎 $BURU 💎 $CHR $GPUS $ADAP Monday to the moon 🚀🚀🚀🚀🚀🌑 All my followers are making bank 🏦 You all gonna be rich 🤑
1 · Reply
Jordanowens356
Jordanowens356 Oct. 3 at 11:41 PM
$ADAP I just want to say I called it🫡
0 · Reply
walfofwallstreet
walfofwallstreet Oct. 3 at 11:32 PM
After hours fire 🔥List🔥👀👀👀🐺 $BURU $CHR $GPUS $ADAP $FEMY Stay tuned everyone👀👀🐺 All my followers are making bank 🏦 You all gonna be rich 🤑
2 · Reply
walfofwallstreet
walfofwallstreet Oct. 3 at 11:14 PM
After hours fire 🔥List🔥👀👀👀🐺 $CHR $BURU $GPUS $ADAP $BTTC Stay tuned everyone👀👀🐺 All my followers are making bank 🏦 You all gonna be rich 🤑
2 · Reply
walfofwallstreet
walfofwallstreet Oct. 3 at 10:48 PM
After hours fire 🔥List🔥👀👀👀🐺 $CHR $ADAP $GPUS $BURU $WORX Stay tuned everyone👀👀🐺 All my followers are making bank 🏦 You all gonna be rich 🤑
2 · Reply
Lacroix71
Lacroix71 Oct. 3 at 10:48 PM
$ADAP c'mon keep the good work.
0 · Reply
walfofwallstreet
walfofwallstreet Oct. 3 at 10:38 PM
After hours fire 🔥List🔥👀👀👀🐺 $ADAP $GPUS $CHR $BURU $BTTX Stay tuned everyone👀👀🐺 All my followers are making bank 🏦 You all gonna be rich 🤑
0 · Reply
JLynneB51671
JLynneB51671 Oct. 3 at 10:21 PM
$BURU $WORX $GPUS $CHR $ADAP Now when is this fire supposed to happen??🤔🤷‍♀️
3 · Reply